Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 10/20 | 0.76 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.76 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.76 |
| ▸ | PGR | P06401 | 1/20 | 0.76 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.76 |
| ▸ | PDE4A | P27815 | 1/20 | 0.76 |
| ▸ | BLVRB | P30043 | 1/20 | 0.76 |
| ▸ | TARBP2 | Q15633 | 1/20 | 0.76 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.76 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.76 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27895928 | 1.00 | XDH (0.76) | XDHABCC4ABCB11PGRCHRM1 | |
| SCHEMBL29460288 | 0.95 | XDH (0.74) | XDHABCC4ABCB11PGRCHRM1 | |
| SCHEMBL19523341 | 0.91 | XDH (0.79) | XDHABCC4ABCB11PGRCHRM1 | |
| SCHEMBL8866996 | 0.91 | XDH (0.72) | XDHABCC4ABCB11PGRCHRM1 | |
| SCHEMBL30804874 | 0.91 | XDH (0.74) | XDHABCC4ABCB11PGRCHRM1 | |
| SCHEMBL29183564 | 0.91 | XDH (0.74) | XDHABCC4ABCB11PGRCHRM1 | |
| SCHEMBL30804875 | 0.90 | XDH (0.73) | XDHABCC4ABCB11PGRCHRM1 | |
| SCHEMBL29183566 | 0.90 | XDH (0.73) | XDHABCC4ABCB11PGRCHRM1 | |
| SCHEMBL8869072 | 0.89 | XDH (0.81) | XDHABCC4ABCB11PGRCHRM1 | |
| SCHEMBL23417559 | 0.86 | XDH (0.85) | XDHABCC4ABCB11PGRCHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111039891-B | Method for synthesizing febuxostat and intermediate thereof | 杭州朱养心药业有限公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-111072591-B | Febuxostat and intermediates and synthesis thereof | 杭州朱养心药业有限公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-110483441-B | Preparation method of febuxostat crystal form A with low impurity content | 迪嘉药业集团股份有限公司 | 2023-02-28 | — | — | CN | disclosed |